ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Biosero Appoints Ryan Bernhardt as Chief Executive Officer

Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced the promotion of Ryan Bernhardt to the position of Chief Executive Officer. Mr. Bernhardt previously served as the company’s Chief Commercial Officer. Tom Gilman, Biosero’s founding CEO and president, will work closely with Mr. Bernhardt through September 30, 2023 to transition responsibilities.

“It is a tremendous privilege to accept the CEO role and to thank Tom for his longtime leadership of this company and wish him all the best in his future endeavors,” said Mr. Bernhardt. “I am very excited about overseeing the next phase of Biosero’s journey as our talented team continues to focus on delivering the best experience possible to our customers, enabling better science and better results.”

In his new capacity, Mr. Bernhardt will continue to lead Biosero’s commercial strategy in addition to furthering the connections between Biosero and the BICO Group.

Mr. Bernhardt joined Biosero in 2021 with more than 15 years of experience in the laboratory automation field. As Chief Commercial Officer, he led Biosero’s sales, marketing, customer success, applications, and business development teams. He was integral in creating new opportunities through strategic partnerships, collaborations, and commercial agreements. He also oversaw the product roadmap for Biosero’s industry-leading Green Button Go automation scheduling software suite.

Before coming to Biosero, Mr. Bernhardt spent more than six years at Eli Lilly and Company as the Global Discovery Automation Research and Technologies Group Leader, where he led a team of automation engineers and scientists in the design, implementation, and operation of a variety of innovative automation initiatives. Prior to that he served as leader of the emerging automation markets global business unit at Hamilton Robotics.

“Since I launched Biosero in 2003, it has been my incredible honor to lead this company through remarkable growth and unparalleled customer successes,” said Mr. Gilman. “Our efforts to transform what’s possible in science through laboratory automation have surpassed my wildest dreams, and that is thanks in large part to Ryan’s vision and expertise. I am so proud to be able to hand over the company to a trusted leader who will maintain its integrity, prioritize customers, and do right by the entire Biosero team.”

About Biosero, Inc.

Biosero, a member of the BICO group, develops science-centric software and laboratory automation solutions that enable researchers to orchestrate their discoveries at every stage. Biosero’s Green Button Go® Scheduler software and integration services match laboratory automation to science, creating a cohesive technology ecosystem that accelerates operations and increases productivity. Additionally, Green Button Go Orchestrator applications provide an end-to-end laboratory management solution, directing workflows and operations in life science, biotechnology, pharmaceutical, and diagnostic research. Biosero is passionate about partnering with organizations dedicated to enhancing life by addressing the world’s most significant needs. For more information, please visit www.biosero.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  234.69
-2.89 (-1.22%)
AAPL  272.41
-0.54 (-0.20%)
AMD  246.81
-1.15 (-0.46%)
BAC  52.61
-0.26 (-0.49%)
GOOG  276.98
-2.14 (-0.77%)
META  609.46
-0.43 (-0.07%)
MSFT  510.18
+6.89 (1.37%)
NVDA  190.17
+3.31 (1.77%)
ORCL  222.85
+5.28 (2.43%)
TSLA  404.35
+2.36 (0.59%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.